Free Trial Information
BioCentury | Jan 7, 2013
Company News

CV Ingenuity, Covidien deal

...CV Ingenuity. The companies, which did not disclose details, expect the deal to close this quarter. CV Ingenuity...
...technology for vascular diseases, including treatment of peripheral artery disease (PAD) and prevention of restenosis. CV Ingenuity...
Read More
BioCentury | Oct 10, 2011
Financial News

CV Ingenuity completes venture financing

CV Ingenuity , Palo Alto, Calif. Business: Cardiovascular Date completed: 10/4/11 Type: Venture financing Raised: $16 million Investors: New Enterprise Associates; BioStar Ventures; Synergy Ventures; Western Technology Investment WIR Staff Cardiovascular...
Read More
BioCentury | Oct 10, 2011
Company News

CV Ingenuity board of directors update

CV Ingenuity , Palo Alto, Calif. Business: Cardiovascular Appointed: Ryan Drant, general partner at New Enterprise Associates; and Justin Klein, principal at New Enterprise Associates WIR Staff...
Read More
BioCentury | Oct 5, 2011
Financial News

CV Ingenuity raises $16 million in series B

...Medical device company CV Ingenuity (Palo Alto, Calif.) raised $16 million in a series B round led...
...Investment also participated. New Enterprise Associates' Ryan Drant and Justin Klein will join CV Ingenuity's board. CV Ingenuity...
Read More
BioCentury | Jul 20, 2009
Company News

Carmot, CV Ingenuity, FibroGen, Gemmus Pharma, Osprey Pharmaceuticals U.S.A., Solidus, California Institute for Quantitative Biosciences other news

...Carmot Therapeutics Inc. , San Francisco, Calif. CV Ingenuity , San Francisco, Calif. FibroGen Inc. , San...
...which is developing small molecules for neurological disorders, metabolic diseases and other unmet medical needs; CV Ingenuity...
Read More
Items per page:
1 - 5 of 5
BioCentury | Jan 7, 2013
Company News

CV Ingenuity, Covidien deal

...CV Ingenuity. The companies, which did not disclose details, expect the deal to close this quarter. CV Ingenuity...
...technology for vascular diseases, including treatment of peripheral artery disease (PAD) and prevention of restenosis. CV Ingenuity...
Read More
BioCentury | Oct 10, 2011
Financial News

CV Ingenuity completes venture financing

CV Ingenuity , Palo Alto, Calif. Business: Cardiovascular Date completed: 10/4/11 Type: Venture financing Raised: $16 million Investors: New Enterprise Associates; BioStar Ventures; Synergy Ventures; Western Technology Investment WIR Staff Cardiovascular...
Read More
BioCentury | Oct 10, 2011
Company News

CV Ingenuity board of directors update

CV Ingenuity , Palo Alto, Calif. Business: Cardiovascular Appointed: Ryan Drant, general partner at New Enterprise Associates; and Justin Klein, principal at New Enterprise Associates WIR Staff...
Read More
BioCentury | Oct 5, 2011
Financial News

CV Ingenuity raises $16 million in series B

...Medical device company CV Ingenuity (Palo Alto, Calif.) raised $16 million in a series B round led...
...Investment also participated. New Enterprise Associates' Ryan Drant and Justin Klein will join CV Ingenuity's board. CV Ingenuity...
Read More
BioCentury | Jul 20, 2009
Company News

Carmot, CV Ingenuity, FibroGen, Gemmus Pharma, Osprey Pharmaceuticals U.S.A., Solidus, California Institute for Quantitative Biosciences other news

...Carmot Therapeutics Inc. , San Francisco, Calif. CV Ingenuity , San Francisco, Calif. FibroGen Inc. , San...
...which is developing small molecules for neurological disorders, metabolic diseases and other unmet medical needs; CV Ingenuity...
Read More
Items per page:
1 - 5 of 5